| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2208923 | A | Drug metabolism in monkey assessed as 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-l, 2,4-oxadiazol-5- yl)piperidin-l -yl)pyrimidin-4-ylamino)benzoic acid metabolite by LC/MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 2. | ALA2208924 | A | Drug metabolism in monkey assessed as 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)benzamide metabolite by LC/MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 3. | ALA2208925 | A | Drug metabolism in monkey assessed as 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)-N-methylbenzamide metabolite by LC/MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 4. | ALA2208964 | A | Drug metabolism in dog assessed as 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-l, 2,4-oxadiazol-5- yl)piperidin-l -yl)pyrimidin-4-ylamino)benzoic acid metabolite by LC/MS/MS analysis | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA2208965 | A | Drug metabolism in dog assessed as 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)benzamide metabolite by LC/MS/MS analysis | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA2208966 | A | Drug metabolism in dog assessed as 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)-N-methylbenzamide metabolite by LC/MS/MS analysis | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA2208967 | A | Drug metabolism in rat assessed as 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-l, 2,4-oxadiazol-5- yl)piperidin-l -yl)pyrimidin-4-ylamino)benzoic acid metabolite by LC/MS/MS analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA2208968 | A | Drug metabolism in rat assessed as 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)benzamide metabolite by LC/MS/MS analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA2208969 | A | Drug metabolism in rat assessed as 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)-N-methylbenzamide metabolite by LC/MS/MS analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA2208970 | A | Drug metabolism in mouse assessed as 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-l, 2,4-oxadiazol-5- yl)piperidin-l -yl)pyrimidin-4-ylamino)benzoic acid metabolite by LC/MS/MS analysis | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA2208971 | A | Drug metabolism in mouse assessed as 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)benzamide metabolite by LC/MS/MS analysis | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA2208972 | A | Drug metabolism in mouse assessed as 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)-N-methylbenzamide metabolite by LC/MS/MS analysis | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA2208973 | F | Agonist activity at GPR119 expressed in CHO-K1 cells assessed as cAMP level after 1 hr by homogenous time-resolved fluorescence assay | 4 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!